Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Israel says 40 Hezbollah members killed as forces advance in Lebanon - 2Robyn returns to music with 'Dopamine,' her 1st single in 7 years: 'Came to save music once again'
- 3Andrew McCarthy's awe-inspiring image of a skydiver in front of the sun
- 4Tata Motors, BMW among automakers set to raise prices in India
- 5Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- Vote In favor of Your Favored Occasion Arranging Administration
- 6 Solid Moving Administrations for a Calm Movement
- How Would You Like to Deal with Your Funds?
- Hamas hands over another body in the Gaza Strip
- I asked ChatGPT who would win a Golden Globes. Here's what it got right — and totally wrong.
- UK can legally stop shadow fleet tankers, ministers believe
- The Best Games On the planet
- Investigating the Financial History of the World: A Succinct Outline
- I tried a macho, creatine-loaded cereal “for men.” Did I mention I'm a woman?
